Skip to main content
Log in

Diagnosis and Treatment of Cognitive Impairments in Attention Deficit Syndrome in Adults

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Objectives. To clarify cognitive impairments in adults with attention deficit hyperactivity syndrome (ADHD) and to assess the efficacy of the formulation Memoplant in the treatment of this pathology. Materials and Methods. The results of clinical, psychological, and electroencephalographic studies of 40 patients aged 18–45 years with ADHD are presented. From recruitment into the study, all patients received Memoplant at a daily dose of 240 mg for eight weeks. Results and conclusions. Adult patients with ADHD had both subjective and objective impairments to memory and attention. EEG results suggested that patients showed dysfunction of the frontothalamic regulatory system and deficit of nonspecific activation by the reticular formation. Courses of Memoplant were followed by clinical improvements in 24 patients (60.0%). Repeat psychological and neurophysiological studies demonstrated decreases in attention deficit and improvements in memory measures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G. Polanczyk, M. S. de Lima, B. L. Horta, J. Biederman, and L. A. Rohde, “The worldwide prevalence of ADHD: a systematic review and metaregression analysis,” Am. J. Psychiatry, 164, No. 6, 942–948 (2007), doi: https://doi.org/10.1176/ajp.2007.164.6.942.

    Article  PubMed  Google Scholar 

  2. P. Rao and M. Place, “Prevalence of ADHD in four general adult outpatient clinics in North East England,” Prog. Neurol. Psychiatry, 15, No. 5, 7–10 (2011), doi: https://doi.org/10.1002/pnp.211.

    Article  Google Scholar 

  3. E. G. Willcutt, “The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review,” Neurotherapeutics, 9, No. 3, 490–499 (2012), doi: https://doi.org/10.1007/s13311-012-0135-8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. J. Fayyad, N. A. Sampson, I. Hwang, et al., “The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys,” Atten. Defic. Hyperact. Disord., 19, 1–19 (2016), doi: https://doi.org/10.1007/s12402-016-0208-3.

    Article  Google Scholar 

  5. I. T. Nureev, M. V. Zlokazova, and V. I. Tsirkin, “Experience in the use of the ASRS V1.1 questionnaire scales for the diagnosis of attention deficit hyperactivity disorder in adults,” Vestn. Pomorsk. Univ. Ser. Giziol. Psychol.-Pedagog. Nauk., 4, 98–102 (2007).

    Google Scholar 

  6. T. Archer, M. Oscar-Berman, and K. Blum, “Epigenetics in developmental disorder: ADHD and endophenotypes,” J. Genet. Syndr. Gene Ther., 2, No. 1, 100–104 (2011), doi: https://doi.org/10.4172/2157-7412.1000104.

    Article  CAS  Google Scholar 

  7. E. Murray, R. Pearson, M. Fernandes, I. S. Santos, F. C. Barros, C. G. Victora, A. Stein, and A. Matijasevich, “Are fetal growth impairment and preterm birth causally related to child attention problems and ADHD? Evidence from a comparison between high-income and middle-income cohorts,” J. Epidemiol. Community Health, 70, No. 7, 704–709 (2016), doi: https://doi.org/10.1136/jech-2015-206222.

    Article  PubMed  PubMed Central  Google Scholar 

  8. O. R. Nogovitsina and E. V. Levitina, “Effects of perinatal risk factors on the formation of attention deficit hyperactivity disorder in children,” Ross. Vestn. Perinatol. Pediatr., 1, 64–65 (2012).

    Google Scholar 

  9. S. V. Faraone and S. A. Khan, “Candidate gene studies of attention-deficit/hyperactivity disorder,” J. Clin. Psychiatry, 67, No. 8, 13–20 (2006).

    CAS  PubMed  Google Scholar 

  10. B. N. Kim, J. W. Kim, and H. Kang, “Regional differences in cerebral perfusion associated with the alpha-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder,” J. Psychiatr. Neurosci., 35, No. 5, 330–336 (2010), doi: https://doi.org/10.1503/jpn.090168.

    Article  Google Scholar 

  11. K. Ding, J. Yang, G. P. Reynolds, B. Chen, J. Shao, R. Liu, Q. Qian, H. Liu, R. Yang, J. Wen, and C. Kang, “DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD,” World J. Biol. Psychiatry, 27, 1–9 (2016), doi: https://doi.org/10.1080/15622975.2016.1224928.

    Article  Google Scholar 

  12. R. M. Alderson, L. J. Kasper, K. L. Hudec, and C. H. Patros, “Attention-deficit/hyperactivity disorder (ADHD) and working memory in adults: a meta-analytic review,” Neuropsychology, 27, No. 3, 287–302 (2013), doi: https://doi.org/10.1037/a0032371.

    Article  PubMed  Google Scholar 

  13. R. N. Elisa, E. Balaguer-Ballester, and B. A. Parris, “Inattention, working memory, and goal neglect in a community sample,” Front. Psychol., 7, 1428 (2016), doi: https://doi.org/10.3389/fpsyg.2016.01428.

    Article  PubMed  PubMed Central  Google Scholar 

  14. K. Murphy, R. Barkley, and T. Bush, “Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history,” J. Nerv. Ment. Dis., 190, 147–157 (2002), doi: https://doi.org/10.1097/00005053-200203000-00003.

    Article  PubMed  Google Scholar 

  15. R. C. Kessler, L. A. Adler, M. J. Gruber, C. A. Sarawate, T. Spencer, and D. L. Van Brunt, “Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) screener in a representative sample of health plan members,” Int. J. Met. Psych. Res., 16, No. 2, 52–65 (2007), doi: https://doi.org/10.1002/mpr.208.

    Article  Google Scholar 

  16. D. E. Broadbent, P. F. Cooper, P. FitzGerald, and K. R. Parkes, “The Cognitive Failures Questionnaire (CFQ) and its correlates,” Br. J. Clin. Psychol., 21, 1–16 (1982), doi: https://doi.org/10.1111/j.2044-8260.1982.tb01421.x.

    Article  PubMed  Google Scholar 

  17. Y. Luo, “Contemporary neuroscience meets traditional medicine – towards understanding Ginkgo biloba neuroprotection,” Curr. Top. Nutraceut. Res., 1, 49–58 (2003).

    CAS  Google Scholar 

  18. F. Tchantchou, P. N. Lacor, Z. Cao, et al., “Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons,” J. Alzheimers Dis., 18, No. 4, 787–798 (2009).

    Article  CAS  Google Scholar 

  19. K. Schwanz, L. Palm, and S. Brallier, “Attention problems and hyperactivity as predictors of college grade point average,” J. Atten. Disord., 11, 368–373 (2007), doi: https://doi.org/10.1177/1087054707305155.

    Article  PubMed  Google Scholar 

  20. S. Blase, A. Gilbert, A. Anastopoulos, et al., “Self-reported ADHD and adjustment in college: cross-sectional and longitudinal findings,” J. Atten. Disord., 3, No. 13, 297–309 (2009), doi: https://doi.org/10.1177/1087054709334446.

  21. R. G. Voigt, S. K. Katusic, R. C. Colligan, J. M. Killian, A. L. Weaver, and W. J. Barbaresi, “Academic achievement in adults with a history of childhood attention-deficit/hyperactivity disorder: A population-based prospective study,” J. Dev. Behav. Pediatr., 23, 1 (2016), doi: https://doi.org/10.1097/dbp.0000000000000358.

    Article  Google Scholar 

  22. R. A. Barkley and M. Fischer, “Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: self-reported executive function (EF) deficits versus EF tests,” Dev. Neuropsychol., 36, 137–161 (2011), doi: https://doi.org/10.1080/87565641.2010.549877.

    Article  PubMed  Google Scholar 

  23. V. A. Grane, T. Endestad, A. F. Pinto, and A. K. Solbakk, “Attentional control and subjective executive function in treatment-naive adults with attention deficit hyperactivity disorder,” PLoS One, 9, No. 12, 115227 (2014), doi: https://doi.org/10.1371/journal.pone.0115227.

    Article  CAS  Google Scholar 

  24. T. Yoshitake, S. Yoshitake, and J. Kehr, “The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex,” Br. J. Pharmacol., 159, No. 3, 659–668 (2010), doi: https://doi.org/10.1111/j.1476-5381.2009.00580.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. A. N. Boiko, A. V. Lebedeva, I. A. Shchukin, et al., “Potential of medication-based correction of moderate cognitive disorder,” Zh. Nevrol. Psikhiat., 2, 28–32 (2013).

    Google Scholar 

  26. I. V. Litvinenko, K. M. Naumov, and M. M. Odinak, “Correction of cognitive and noncognitive symptoms of cerebrovascular disease,” Zh. Nevrol. Psikhiat., 4, 35–40 (2014).

    Google Scholar 

  27. L. S. Chutko, S. Yu. Surushkina, A. V. Rozhkova, I. S. Nikishena, and E. A. Yakovenko, “Asthenic symptoms complex in patients with emotional burnout syndrome,” Zh. Nevrol. Psikhiat., No. 11, 22–26 (2013).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. S. Chutko.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 117, No. 5, Iss. 1, pp. 9–13, May, 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chutko, L.S., Surushkina, S.Y., Yakovenko, E.A. et al. Diagnosis and Treatment of Cognitive Impairments in Attention Deficit Syndrome in Adults. Neurosci Behav Physi 49, 115–120 (2019). https://doi.org/10.1007/s11055-018-0703-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-018-0703-4

Keywords

Navigation